AVITA Medical 

Based in Valencia, California, AVITA Medical Inc. is a commercial-stage company established in 2000, specializing in regenerative tissue solutions. Operating across the United States, Australia, and the United Kingdom, the company addresses significant medical challenges such as burn and trauma injuries, chronic wounds, and dermatological conditions including vitiligo. At the heart of AVITA Medical's offerings is a proprietary and patented technology platform that leverages the body's natural regenerative properties by utilizing a patient's own skin to create therapeutic treatments. Its flagship product, the RECELL System, empowers healthcare providers to generate a "Spray-On Skin" cell suspension from a minimal skin sample, primarily for the treatment of acute thermal burns in adults (aged 18 and above). Beyond its commercial endeavors, AVITA Medical actively pursues advanced research, collaborating with the University of Colorado School of Medicine on pre-clinical studies for spray-on genetically corrected cells, and with the Houston Methodist Research Institute to investigate molecular reversal of cellular aging through a novel cell suspension delivery approach. The company adopted its current name, AVITA Medical Inc., in December 2020, having previously traded as AVITA Therapeutics, Inc.